|
pA2 online
© Copyright 2004 The British Pharmacological Society
|
124P
GKT, University of London
Winter Meeting December 2003
|
Chronic
psychosocial stress in tree shrews down-regulates the GluR2 subunit
in the prefrontal cortex
1M.
Albert, 1G. Flügge, 1E.
Fuchs, 2M. B. Hesselink, 3G.J.
Michael, 3A.T Michael-Titus. 1
Clinical Neurobiology Laboratory, German Primate Center, Kellnerweg
4, 37077 Gottingen, Germany, 2Solvay
Pharmaceuticals, CJ van Houtenlaan 36, Da Weesp, 1380 Netherlands,
3Department of Neuroscience, Queen
Mary College, University of London, Mile End Road, London E1 4NS,
United Kingdom.
|
Print abstract
Search PubMed for:
Albert M
Flügge G
Fuchs E
Hesselink MB
Michael GJ
Michael-Titus AT
|
Converging evidence
suggests a link between stress, depression and excitatory amino acids
in the prefrontal cortex (Moghaddam , 1993; Jedema and Moghaddam, 1994).
We have shown that chronic treatment with the tricyclic antidepressant
imipramine reduces glutamate release in rat prefrontal cortex and increases
the expression of the GluR2 subunit of the AMPA ( -amino-3-hydroxy-5-methyl-4-isoxazole-propionic
acid) receptor (Michael-Titus et al., 2000; Nazir et al., 2002). In this
study we have investigated changes in GluR2 expression in a stress model
in tree shrews. In this model we have also tested the effects of the new
compound SONU20176289 (7-{4-[3-(5-fluoro-1H-indol-3-yl) - propyl] - piperazin-1-yl}
-3H-benzooxazol-2-one). This compound shows in vitro and in vivo a combined
dopaminergic and serotonergic profile (SSRI activity combined with partial
5-HT1A agonist and partial dopamine D2
agonist activity). Male adult tree shrews were submitted to chronic psychosocial
stress as previously described (Fuchs et al., 1996). SONU20176289 (or
the vehicle) was administered orally at 6 mg/kg/day for 4 weeks. At the
end of the experiments animals were anaesthetised and perfused with 4%
paraformaldehyde and brain sections (30 microns) were stained with a GluR2
antibody (concentration 1:500, Chemicon, UK) with the diaminobenzidine
method. The staining intensity was analysed in two non-overlapping fields
in the prefrontal region. The labelling of cells was quantified by densitometry
in one section per animal. The average cell signal minus the surrounding
background signal was calculated for 180-200 cells in each section, and
was expressed in arbitrary units. Means ± SEM obtained with 3-5
animals per group were compared with two-way ANOVA followed by Bonferroni's
t test. Stress induced a significant decrease in GluR2 staining. Thus,
in field 1 the mean ± SEM staining in controls was 68.25 ±
4.01 vs. 40.2 ±3.66 in stressed animals (P<0.05), i.e. a stress-associated
decrease in signal of 41% compared to controls. SONU20176289 had no intrinsic
effect on GluR2, but fully reversed the effects of stress (58.17 ±
4.72 and 63 ± 4.09, respectively). The analysis showed a significant
interaction between stress and treatment (P<0.01). Similar results
were obtained in field 2: the staining in controls was 62.75 ±
2.83 vs. 39.4 ±2.53 in stressed animals (P<0.05), and this was
reversed in treated animals (58.25 ± 2.83). These observations
show that stress can trigger significant changes in the GluR2 subunit.
This subunit confers low calcium permeability to AMPA receptors (Hollmann
et al., 1991) and its decrease may lead to an increased risk of intracellular
calcium overload. Interestingly, a decrease in GluR2 transcripts in the
dorsolateral prefrontal cortex in major depression has recently been reported
(Beneyto and Meador-Woodruff, 2002). Treatment with compounds with antidepressant
potential may have a long-term neuroprotective role, as postulated previously
(Michael-Titus et al., 2000).
Beneyto, M. and Meador-Woodruff,
H. (2002) Soc. Neurosci. Abstr. 497.16.
Fuchs, E. et al. (1996) Pharmacol. Biochem. Behav., 54,
219-228.
Hollmann, M. et al (1991) Science, 252, 851-853.
Jedema, H.P.and Moghaddam, B (1994) J. Neurochem., 63, 785-788.
Michael-Titus, A. T. et al. (2000) Neuroscience , 100, 681-684.
Moghaddam, B. (1993) J. Neurochem., 60, 785-788.
Nazir, S. et al. (2002) Br. J. Pharmac., 135 (Proc. Suppl),
370P.
|